The HIV + Hepatitis Policy Institute, a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions, is pleased to submit comments on the proposed Notice of Benefit…
Cost-sharing for prescription drugs; Comments on 2021 notice of benefit and payment parameters proposed rule
read more